Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription

Articles published in Radiology

Retrieve available abstracts of 61 articles:
HTML format

Single Articles

    May 2024
  1. LIN Y, Yilmaz EC, Belue MJ, Harmon SA, et al
    Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
    Radiology. 2024;311:e230750.
    PubMed     Abstract available

    April 2024
  2. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e231703.
    PubMed     Abstract available

    March 2024
    Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    Radiology. 2024;310:e240258.

  4. GHAI S, Finelli A, Corr K, Lajkosz K, et al
    MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
    Radiology. 2024;310:e231473.
    PubMed     Abstract available

    December 2023
  5. MURAD V, Glicksman RM, Berlin A, Santiago A, et al
    Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
    Radiology. 2023;309:e231407.
    PubMed     Abstract available

  6. ALABOUSI M, Ghai S, Haider MA
    MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
    Radiology. 2023;309:e230431.
    PubMed     Abstract available

    PSMA PET Parameters for Predicting Outcomes in Patients with Prostate Cancer.
    Radiology. 2023;309:e233023.

    November 2023
    Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
    Radiology. 2023;309:e231177.

  9. AGUIRRE DA, Cardona Ortegon JD
    Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
    Radiology. 2023;309:e232819.

  10. LUZZAGO S, Colombo A, Mistretta FA, Alessi S, et al
    Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
    Radiology. 2023;309:e223349.
    PubMed     Abstract available

    September 2023
  11. BISCHOFF LM, Peeters JM, Weinhold L, Krausewitz P, et al
    Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
    Radiology. 2023;308:e230427.
    PubMed     Abstract available

    July 2023
  12. GAFITA A, Djaileb L, Rauscher I, Fendler WP, et al
    Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
    Radiology. 2023;308:e222148.
    PubMed     Abstract available

  13. WEI C, Szewczyk-Bieda M, Bates AS, Donnan PT, et al
    Multicenter Randomized Trial Assessing MRI and Image-guided Biopsy for Suspected Prostate Cancer: The MULTIPROS Study.
    Radiology. 2023;308:e221428.
    PubMed     Abstract available

    June 2023
  14. PADHANI AR, Schoots IG
    Imaging-based Diagnostic and Therapeutic Strategies for Prostate Cancer in the Coming Decades.
    Radiology. 2023;307:e222990.

  15. TURKBEY B, Purysko AS
    PI-RADS: Where Next?
    Radiology. 2023;307:e223128.
    PubMed     Abstract available

    May 2023
  16. YILMAZ EC, Shih JH, Belue MJ, Harmon SA, et al
    Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers.
    Radiology. 2023 May 2:221309. doi: 10.1148/radiol.221309.
    PubMed     Abstract available

  17. GOH V
    PI-RADS and Multiparametric MRI: The Shape of Things to Come for Prostate Cancer.
    Radiology. 2023 May 2:230643. doi: 10.1148/radiol.230643.

    April 2023
  18. SEIFERT R, Rasul S, Seitzer K, Eveslage M, et al
    A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.
    Radiology. 2023 Apr 18:222010. doi: 10.1148/radiol.222010.
    PubMed     Abstract available

    Reawakening of Nuclear Medicine through Molecular Imaging: Quantitative Theranostics and PSMA PET.
    Radiology. 2023 Apr 18:230627. doi: 10.1148/radiol.230627.

  20. HAMM CA, Baumgartner GL, Biessmann F, Beetz NL, et al
    Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Radiology. 2023 Apr 11:222276. doi: 10.1148/radiol.222276.
    PubMed     Abstract available

    Explainable AI for Prostate MRI: Don't Trust, Verify.
    Radiology. 2023 Apr 11:230574. doi: 10.1148/radiol.230574.

    February 2023
  22. SCIALPI M, Martorana E, Scalera GB, Scialpi P, et al
    Apparent Diffusion Coefficient and Lesion Volume to Detect Prostate Cancer.
    Radiology. 2023 Feb 28:222177. doi: 10.1148/radiol.222177.

    December 2022
  23. STAVRINIDES V, Norris JM, Karapanagiotis S, Giganti F, et al
    Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
    Radiology. 2022 Dec 13:220762. doi: 10.1148/radiol.220762.
    PubMed     Abstract available

    September 2022
  24. PARIHAR AS, Hofman MS, Iravani A
    (177)Lu-Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer.
    Radiology. 2022 Sep 20:220859. doi: 10.1148/radiol.220859.
    PubMed     Abstract available

    August 2022
  25. GOH V
    Tumor Physiology and Clinically Significant Prostate Cancer Detection.
    Radiology. 2022 Aug 16:221798. doi: 10.1148/radiol.221798.

  26. TAVAKOLI AA, Hielscher T, Badura P, Gortz M, et al
    Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2022 Aug 16:212692. doi: 10.1148/radiol.212692.
    PubMed     Abstract available

  27. SINGH S, Rogers H, Kanber B, Clemente J, et al
    Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
    Radiology. 2022 Aug 2:212536. doi: 10.1148/radiol.212536.
    PubMed     Abstract available

    July 2022
  28. LEE GH, Chatterjee A, Karademir I, Engelmann R, et al
    Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
    Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
    PubMed     Abstract available

    Hybrid Multidimensional Prostate MRI: A Quantitative Step in the Right Direction.
    Radiology. 2022 Jul 26:221452. doi: 10.1148/radiol.221452.

    (18)F-DCFPyL PET/CT in Men with Prostate Cancer.
    Radiology. 2022 Jul 19:221536. doi: 10.1148/radiol.221536.

  31. ULANER GA, Thomsen B, Bassett J, Torrey R, et al
    (18)F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation.
    Radiology. 2022 Jul 19:220218. doi: 10.1148/radiol.220218.
    PubMed     Abstract available

  32. GHAI S, Perlis N, Atallah C, Jokhu S, et al
    Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
    Radiology. 2022 Jul 19:212163. doi: 10.1148/radiol.212163.
    PubMed     Abstract available

    May 2022
  33. JADVAR H
    Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.
    Radiology. 2022 May 24:221074. doi: 10.1148/radiol.221074.

  34. BASSO DIAS A, Finelli A, Bauman G, Veit-Haibach P, et al
    Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.
    Radiology. 2022 May 24:211836. doi: 10.1148/radiol.211836.
    PubMed     Abstract available

    It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence.
    Radiology. 2022 May 10:220701. doi: 10.1148/radiol.220701.

  36. PECORARO M, Turkbey BI, Purysko AS, Girometti R, et al
    Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
    PubMed     Abstract available

    March 2022
  37. WU D, Jiang K, Li H, Zhang Z, et al
    Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer.
    Radiology. 2022 Mar 8:211180. doi: 10.1148/radiol.211180.
    PubMed     Abstract available

    Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI.
    Radiology. 2022 Mar 8:220056. doi: 10.1148/radiol.220056.

    February 2022
  39. KUMAR R, Singh SK, Mittal BR, Vadi SK, et al
    Safety and Diagnostic Yield of (68)Ga Prostate-specific Membrane Antigen PET/CT Guided Robotic-assisted Transgluteal Prostatic Biopsy.
    Radiology. 2022 Feb 22:204066. doi: 10.1148/radiol.204066.
    PubMed     Abstract available

  40. UEDA T, Ohno Y, Yamamoto K, Murayama K, et al
    Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging.
    Radiology. 2022 Feb 1:204097. doi: 10.1148/radiol.204097.
    PubMed     Abstract available

    January 2022
    Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of (18)F-DCFPyL PET/CT.
    Radiology. 2022 Jan 25:212993. doi: 10.1148/radiol.212993.

  42. METSER U, Zukotynski K, Mak V, Langer D, et al
    Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2022 Jan 25:211824. doi: 10.1148/radiol.211824.
    PubMed     Abstract available

  43. RANASINGHE WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, et al
    Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
    Radiology. 2022 Jan 25:204732. doi: 10.1148/radiol.204732.
    PubMed     Abstract available

  44. LAMBERG H, Shankar PR, Singh K, Caoili EM, et al
    Preoperative Prostate MRI Predictors of Urinary Continence Following Radical Prostatectomy.
    Radiology. 2022 Jan 18:210500. doi: 10.1148/radiol.210500.
    PubMed     Abstract available

  45. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
    Case 297: Mucinous Adenocarcinoma of the Prostate.
    Radiology. 2022;302:238-242.
    PubMed     Abstract available

    December 2021
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.

  47. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed     Abstract available

    November 2021
  48. CHATTERJEE A, Mercado C, Bourne RM, Yousuf A, et al
    Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings.
    Radiology. 2021 Nov 9:204459. doi: 10.1148/radiol.2021204459.
    PubMed     Abstract available

  49. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021;301:E418.

    October 2021
  50. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021;301:E380.

    August 2021
  51. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.

  52. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
    Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
    PubMed     Abstract available

    July 2021
  53. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
    PubMed     Abstract available

    May 2021
  54. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
    Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
    PubMed     Abstract available

  55. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.

  56. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.

    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.

    April 2021
  58. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available

  59. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.

    February 2021
  60. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.

    November 2020
  61. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.